Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Cancer Genetics' MatBA-CLL/SLL Test

Premium

Cancer Genetics this week launched an updated version of its MatBA-CLL/SLL test for mature B-cell neoplasms, which provides greater clarity of risk and outcomes for patients with chronic lymphocytic leukemia and small lymphocytic lymphoma.

According to the Rutherford, NJ-based company, its microarray-based test now reports information on twenty genomic sites, enabling the stratification of CLL and SLL patients into three distinct risk categories: favorable, intermediate, and unfavorable.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.